Peptidomics: A New Dimension in Microbiome Research

Area of Science:

• Microbiome Research
• Host-Microbiome Interactions
• Biomarker Discovery

Background:

• The human gut microbiome significantly impacts health, influencing digestion, immunity, metabolism, and disease.
• Current methods like metagenomics and metabolomics provide incomplete functional insights into the microbiome.
• Microbial imbalances are linked to various diseases, but underlying mechanisms require further elucidation.

Purpose of the Study:

• To highlight peptidomics as a critical, underutilized dimension for understanding microbiome function.
• To emphasize peptidomics' potential in capturing host-microbiome interactions and disease mechanisms.
• To advocate for the integration of peptidomics into mainstream microbiome research.

Main Methods:

• Utilizing peptide-enriching, protease-inhibiting workflows.
• Employing high-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS).
• Leveraging gut-specific peptide databases (e.g., MetaPep) and AI for peptide analysis.

Main Results:

• Peptidomics directly captures unstable signaling peptides and proteolytic fragments missed by conventional proteomics.
• Peptide-level resolution reveals microbial roles in gut inflammation and modulates the gut-brain axis.
• Peptidomics enables peptide-based disease stratification, as seen in inflammatory bowel disease.

Conclusions:

• Peptidomics offers a concrete technical route to decipher the functional peptide layer of the microbiome.
• Integrating peptidomics with genomics, transcriptomics, and metabolomics will yield a more complete microbiome picture.
• This integration will accelerate biomarker discovery, refine diagnostics, and advance peptide-based therapeutics.